Mark C. Steckel
Technik-/Wissenschafts-/F&E-Leiter bei Biosensors
Profil
Mark C.
Steckel was the founder of Zorion Medical, Inc. founded in 2010, where he held the title of Chief Technical Officer.
He is currently the Head of Research & Development at Biosensors.
Dr. Steckel's former positions include Program Director at Biotronik AG, Principal at Johnson & Johnson, Principal at Boston Scientific Corp., and Vice President of Research & Development at Cappella, Inc. Dr. Steckel received his undergraduate and graduate degrees from Drexel University and his doctorate from the Massachusetts Institute of Technology.
Aktive Positionen von Mark C. Steckel
| Unternehmen | Position | Beginn |
|---|---|---|
| Biosensors | Technik-/Wissenschafts-/F&E-Leiter | 24.10.2011 |
Ehemalige bekannte Positionen von Mark C. Steckel
| Unternehmen | Position | Ende |
|---|---|---|
Biotronik AG
 Biotronik AG Medical SpecialtiesHealth Technology Part of BIOTRONIK SE & Co. KG, Biotronik AG is a Swiss medical device company that specializes in coronary balloon catheters. The company is based in Bulach, Switzerland. The "ProMRI MR conditional device systems" manual provides information on the combination of MR conditional devices. | Corporate Officer/Principal | - |
Zorion Medical, Inc.
 Zorion Medical, Inc. Medical SpecialtiesHealth Technology Zorion Medical, Inc. develops absorbable medical device platform targeting treatment of coronary and peripheral artery disease. Its product includes absorbable drug-eluting stent, which is developed to treat cardiovascular diseases. The company was founded by Yanni Pandelidis, David A. Broecker and Mark C. Steckel in 2010 and is headquartered in Zionsville, IN. | Gründer | - |
| JOHNSON & JOHNSON | Corporate Officer/Principal | - |
| BOSTON SCIENTIFIC CORPORATION | Corporate Officer/Principal | - |
Cappella, Inc.
 Cappella, Inc. Pharmaceuticals: MajorHealth Technology Cappella, Inc. operates as a medical device company, which develops novel solutions for the treatment of complex coronary artery disease (CAD) and specifically bifurcation vascular disease. The company was founded by Antonio Columbo and Ascher Shmulewitz in 2004 and is headquartered in Boston, MA. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Mark C. Steckel
| Drexel University | Graduate Degree |
| Massachusetts Institute of Technology | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| BOSTON SCIENTIFIC CORPORATION | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Cappella, Inc.
Cappella, Inc. Pharmaceuticals: MajorHealth Technology Cappella, Inc. operates as a medical device company, which develops novel solutions for the treatment of complex coronary artery disease (CAD) and specifically bifurcation vascular disease. The company was founded by Antonio Columbo and Ascher Shmulewitz in 2004 and is headquartered in Boston, MA. | Health Technology |
Zorion Medical, Inc.
Zorion Medical, Inc. Medical SpecialtiesHealth Technology Zorion Medical, Inc. develops absorbable medical device platform targeting treatment of coronary and peripheral artery disease. Its product includes absorbable drug-eluting stent, which is developed to treat cardiovascular diseases. The company was founded by Yanni Pandelidis, David A. Broecker and Mark C. Steckel in 2010 and is headquartered in Zionsville, IN. | Health Technology |
Biotronik AG
Biotronik AG Medical SpecialtiesHealth Technology Part of BIOTRONIK SE & Co. KG, Biotronik AG is a Swiss medical device company that specializes in coronary balloon catheters. The company is based in Bulach, Switzerland. The "ProMRI MR conditional device systems" manual provides information on the combination of MR conditional devices. | Health Technology |
| Biosensors |
